Biotech · Private company
Xilio Development, Inc.
Track this companyFree. Adds Xilio Development, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AtezolizumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- vilastobart (XTX101)Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- XTX202Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- XTX301Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- XTX501Phase 2 · Metastatic NSCLC - Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PCPHASE2 · NOT_YET_RECRUITING · started Jan 1, 2027ClinicalTrials.gov NCT07765836 · fetched Nov 12, 2026
- XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Oct 21, 2026ClinicalTrials.gov NCT07688577 · fetched Nov 12, 2026
- XTX301 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started May 11, 2023ClinicalTrials.gov NCT05684965 · fetched Nov 12, 2026
- XTX202 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started Jan 18, 2022ClinicalTrials.gov NCT05052268 · fetched Nov 12, 2026
- Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started Sep 13, 2021ClinicalTrials.gov NCT04896697 · fetched Nov 12, 2026